Your session is about to expire
← Back to Search
ePRO Monitoring for Chronic Disease Care Transitions
Study Summary
This trial aims to develop a system to identify and predict patient symptoms after discharge in order to minimize adverse events. The system will use patient-reported symptoms and predictive algorithms to escalate to inpatient and ambulatory clinicians. The study will be conducted with patients who have multiple chronic conditions and will be evaluated for its impact on post-discharge adverse events.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have two or more chronic conditions from a specified list.I or my healthcare proxy can communicate in English.I was in the hospital for less than a day.I am 18 years old or older.I am under 18 years old.I have been in the hospital for at least a day.
- Group 1: Usual Care (Arm 1)
- Group 2: Usual Care (Arm 2)
- Group 3: Intervention (Arm 3)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new participants being accepted for this clinical trial?
"According to information listed on clinicaltrials.gov, this medical research is currently recruiting patients and has been since February 1st 2022. The trial underwent a final update on March 7th 2022."
Could you apprise me of the upper limit in regards to how many volunteers are taking part in this experiment?
"Affirmative. The clinicaltrials.gov website reveals that this medical trial, first publicized on February 1st 2022, is still in search of participants. 1300 individuals are required to be recruited from 2 locations."
Share this study with friends
Copy Link
Messenger